RHYTHM AI’s £2.15 Million Seed Financing Round

Osborne Clarke has advised RHYTHM AI, a UK company focused on the treatment of Atrial Fibrillation, on the closure of a £2.15m seed financing round. AF…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now